Cargando…

Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease

Background: National Institute on Aging—Alzheimer's Association (NIA-AA) proposed the AT(N) system based on β-amyloid deposition, pathologic tau, and neurodegeneration, which considered the definition of Alzheimer's disease (AD) as a biological construct. However, the associations between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Rong-Rong, Xue, Yan-Yan, Li, Xiao-Yan, Chen, Yi-He, Tao, Qing-Qing, Wu, Zhi-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377373/ https://www.ncbi.nlm.nih.gov/pubmed/34421579 http://dx.doi.org/10.3389/fnagi.2021.718959

Ejemplares similares

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
por: Chen, Yi-He, et al.
Publicado: (2022)

Early Diagnosis of Alzheimer’s Disease: Moving Toward a Blood-Based Biomarkers Era
por: Tao, Qing-Qing, et al.
Publicado: (2023)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Screening of Human Circular RNAs as Biomarkers for Early Onset Detection of Alzheimer’s Disease
por: Zheng, Da, et al.
Publicado: (2022)

Effects of Subcortical Atrophy and Alzheimer’s Pathology on Cognition in Elderly Type 2 Diabetes: The Alzheimer’s Disease Neuroimaging Initiative Study
por: Zhang, Wen, et al.
Publicado: (2022)

Application of Cerebrospinal Fluid AT(N) Framework on the Diagnosis of AD and Related Cognitive Disorders in Chinese Han Population
por: Ye, Ling-Qi, et al.
Publicado: (2021)

Longitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer’s Disease Biomarkers and Mood Symptoms
por: Munro, Catherine E., et al.
Publicado: (2022)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis
por: Xing, Wenmin, et al.
Publicado: (2021)

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study
por: Wang, Hao, et al.
Publicado: (2023)

Editorial: Immunological Mechanisms, Biomarkers and Immunotherapies of Alzheimer's Disease
por: Xin, Jia-yan, et al.
Publicado: (2021)

Correlation Between Cerebral Venous Oxygen Level and Cognitive Status in Patients With Alzheimer’s Disease Using Quantitative Susceptibility Mapping
por: Liu, YangYingQiu, et al.
Publicado: (2021)

Effectiveness of Physical Activity Interventions on Cognition, Neuropsychiatric Symptoms, and Quality of Life of Alzheimer’s Disease: An Update of a Systematic Review and Meta-Analysis
por: Liang, Ya-Jing, et al.
Publicado: (2022)

Optimized Magnetic Stimulation Induced Hypoconnectivity Within the Executive Control Network Yields Cognition Improvements in Alzheimer’s Patients
por: Xiao, Guixian, et al.
Publicado: (2022)

Longitudinal Intraindividual Cognitive Variability Is Associated With Reduction in Regional Cerebral Blood Flow Among Alzheimer’s Disease Biomarker-Positive Older Adults
por: Holmqvist, Sophia L., et al.
Publicado: (2022)

Systematic evaluation of urinary formic acid as a new potential biomarker for Alzheimer’s disease
por: Wang, Yifan, et al.
Publicado: (2022)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Progressive Brain Degeneration From Subjective Cognitive Decline to Amnestic Mild Cognitive Impairment: Evidence From Large-Scale Anatomical Connection Classification Analysis
por: Tao, Wuhai, et al.
Publicado: (2021)

Longitudinal associations between sleep duration and cognitive impairment in Chinese elderly
por: Chen, Wei-chao, et al.
Publicado: (2022)

Deep Learning Model for Prediction of Progressive Mild Cognitive Impairment to Alzheimer’s Disease Using Structural MRI
por: Lim, Bing Yan, et al.
Publicado: (2022)

The Coupled Representation of Hierarchical Features for Mild Cognitive Impairment and Alzheimer's Disease Classification
por: Liu, Ke, et al.
Publicado: (2022)

Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
por: Zhao, Aonan, et al.
Publicado: (2020)

Detection of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Longitudinal Brain MRI
por: Sun, Zhuo, et al.
Publicado: (2017)

Brain region-specific genome-wide deoxyribonucleic acid methylation analysis in patients with Alzheimer’s disease
por: Ren, Gang, et al.
Publicado: (2023)

Associations of Lifestyle Factors With Cognition in Community-Dwelling Adults Aged 50 and Older: A Longitudinal Cohort Study
por: Huang, Zhezhou, et al.
Publicado: (2020)

Classification of Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Unimpaired Individuals Using Multi-feature Kernel Discriminant Dictionary Learning
por: Li, Qing, et al.
Publicado: (2018)

An N400 identification method based on the combination of Soft-DTW and transformer
por: Ma, Yan, et al.
Publicado: (2023)

Increased Posterior Insula-Sensorimotor Connectivity Is Associated with Cognitive Function in Healthy Participants with Sleep Complaints
por: Liu, Chun-Hong, et al.
Publicado: (2018)

Comparison of brain microstructure alterations on diffusion kurtosis imaging among Alzheimer’s disease, mild cognitive impairment, and cognitively normal individuals
por: Chu, Xiaoqi, et al.
Publicado: (2022)

The cognitive dysfunction of claustrum on Alzheimer’s disease: A mini-review
por: Chen, Chun-Yan, et al.
Publicado: (2023)

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
por: Vemuri, Prashanthi, et al.
Publicado: (2011)

Brain Atrophy and Clinical Characterization of Adults With Mild Cognitive Impairment and Different Cerebrospinal Fluid Biomarker Profiles According to the AT(N) Research Framework of Alzheimer’s Disease
por: Rivas-Fernández, Miguel Ángel, et al.
Publicado: (2022)

Dynamic Complexity of Spontaneous BOLD Activity in Alzheimer’s Disease and Mild Cognitive Impairment Using Multiscale Entropy Analysis
por: Niu, Yan, et al.
Publicado: (2018)

Neuroprotective Effect of Resveratrol via Activation of Sirt1 Signaling in a Rat Model of Combined Diabetes and Alzheimer’s Disease
por: Ma, XingRong, et al.
Publicado: (2020)

Association of N-nitrosodimethylamine exposure with cognitive impairment based on the clues of mice and humans
por: Liu, Wei, et al.
Publicado: (2023)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis
por: Yu, Wuhan, et al.
Publicado: (2021)

Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease
por: Insel, Philip S, et al.
Publicado: (2015)

The association of serum uric acid with cognitive impairment and ATN biomarkers
por: Huang, Shan, et al.
Publicado: (2022)

Visual Abnormalities Associate With Hippocampus in Mild Cognitive Impairment and Early Alzheimer's Disease
por: Zhao, Aonan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ap204jndlrd1fguccavm2sgj8e